When assessing chemical safety, most regulatory frameworks still evaluate substances individually. However, in our daily lives, we are environmentally exposed to a wide variety of substances – via the air we breath, the water we drink, the food we eat and the many consumer products we use every day. The NEMESIS project takes a crucial step forward […]

In October 2024, the Wincent Lab at Karolinska Institutet started testing the effects of NEMESIS focus-compounds on adverse outcomes using zebrafish, a non-mammalian model, as part of the in vivo work done in the NEMESIS project. Malin Lundvall, a Master’s student, and Oscar Diaz, Postdoc, performed the initial testing and evaluated the effects of 8 […]

NEMESIS has run for just over one year and it was time to see where the project is at. The consortium members met at a General Assembly meeting in Barcelona on 29-30 January 2025 to discuss the progress of the project and the next steps. The meeting was arranged at CSIC Spanish National Research Council […]

Subscribe now to receive in your inbox the ENKORE Cluster newsletter on the latest news and advances on the health impacts of endocrine-disrupting chemicals from European research institutions and five Horizon Europe funded projects: NEMESIS as well as EDC-MASLD, ENDOMIX, HYPIEND and MERLON. During the ENKORE cluster lifespan, just a total of three newsletters will be sent with cluster […]

ENKORE is a cluster on endocrine disrupting chemicals and knowledge on health-related effects. The website of the cluster is now open! ENKORE is a cluster of five research projects from the call HORIZON-HLTH-2023-ENVHLTH-02-03 “Health impacts of endocrine-disrupting chemicals: bridging science-policy gaps by addressing persistent scientific uncertainties”. The cluster aims to strengthen collaboration, avoid duplication and […]

NEMESIS was created with the vision of identifying metabolism disrupting chemicals (MDCs) causing adverse metabolic effects and increasing mechanistic understanding of adverse metabolic effects of MDCs in liver, pancreas, and microbiota. Ultimately, the NEMESIS aims to develop novel effect biomarkers for metabolic disruptors, providing evidence on their health impacts. With a consortium of 14 partners […]

Last Friday we kicked-off the new ENKORE Cluster in Brussels. The ENKORE Cluster consists of five research projects funded by the Horizon Europe programme, to study endocrine disrupting chemicals. We are very excited to get the cluster activities going with our sister-projects MERLON, HYPIEND, EDC-MASLD and ENDOMIX!

Finally the NEMESIS consortium members met in person! The first face-to-face NEMESIS project meeting was arranged in sunny Helsinki on 23 – 24 May 2024. Thirty scientists gathered together to work, present and discuss the tasks, progress, and plans of the work packages and the project as a whole.

Exciting! The NEMESIS kick-off meeting took place online on 23 and 26 February 2024.